These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 12360427)
1. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Yao FY; Bass NM; Nikolai B; Davern TJ; Kerlan R; Wu V; Ascher NL; Roberts JP Liver Transpl; 2002 Oct; 8(10):873-83. PubMed ID: 12360427 [TBL] [Abstract][Full Text] [Related]
2. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Graziadei IW; Sandmueller H; Waldenberger P; Koenigsrainer A; Nachbaur K; Jaschke W; Margreiter R; Vogel W Liver Transpl; 2003 Jun; 9(6):557-63. PubMed ID: 12783395 [TBL] [Abstract][Full Text] [Related]
3. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Yao FY; Bass NM; Nikolai B; Merriman R; Davern TJ; Kerlan R; Ascher NL; Roberts JP Liver Transpl; 2003 Jul; 9(7):684-92. PubMed ID: 12827553 [TBL] [Abstract][Full Text] [Related]
4. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Yao FY; Bass NM; Ascher NL; Roberts JP Liver Transpl; 2004 May; 10(5):621-30. PubMed ID: 15108253 [TBL] [Abstract][Full Text] [Related]
5. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Lu DS; Yu NC; Raman SS; Lassman C; Tong MJ; Britten C; Durazo F; Saab S; Han S; Finn R; Hiatt JR; Busuttil RW Hepatology; 2005 May; 41(5):1130-7. PubMed ID: 15841454 [TBL] [Abstract][Full Text] [Related]
6. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Decaens T; Roudot-Thoraval F; Hadni-Bresson S; Meyer C; Gugenheim J; Durand F; Bernard PH; Boillot O; Sulpice L; Calmus Y; Hardwigsen J; Ducerf C; Pageaux GP; Dharancy S; Chazouilleres O; Cherqui D; Duvoux C Liver Transpl; 2006 Dec; 12(12):1761-9. PubMed ID: 16964590 [TBL] [Abstract][Full Text] [Related]
7. An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Pelletier SJ; Fu S; Thyagarajan V; Romero-Marrero C; Batheja MJ; Punch JD; Magee JC; Lok AS; Fontana RJ; Marrero JA Liver Transpl; 2009 Aug; 15(8):859-68. PubMed ID: 19642139 [TBL] [Abstract][Full Text] [Related]
8. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list. Fisher RA; Maluf D; Cotterell AH; Stravitz T; Wolfe L; Luketic V; Sterling R; Shiffman M; Posner M Clin Transplant; 2004 Oct; 18(5):502-12. PubMed ID: 15344951 [TBL] [Abstract][Full Text] [Related]
9. Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Silva M; Moya A; Berenguer M; Sanjuan F; López-Andujar R; Pareja E; Torres-Quevedo R; Aguilera V; Montalva E; De Juan M; Mattos A; Prieto M; Mir J Liver Transpl; 2008 Oct; 14(10):1449-60. PubMed ID: 18825681 [TBL] [Abstract][Full Text] [Related]
10. Preliminary results of liver transplantation for hepatocellular carcinoma among allocation organ policy strategies, neoadjuvant treatments, and intention-to-treat analysis. Andorno E; Bottino G; Morelli N; Casaccia M; Gelli M; Piredda D; Immordino G; Ferrante R; Nardi I; Troilo BM; Di Domenico S; Ravazzoni F; Valente U Transplant Proc; 2008; 40(6):1972-3. PubMed ID: 18675103 [TBL] [Abstract][Full Text] [Related]
11. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria. Santoyo J; Sanchez B; de la Mata M; Fernández-Aguilar JL; Lopez-Ciller P; Pascasio JM; Suarez MA; Gomez MA; Nogueras F; Muffak K; Cuende N; Alonso M Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412 [TBL] [Abstract][Full Text] [Related]
12. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Yao FY; Hirose R; LaBerge JM; Davern TJ; Bass NM; Kerlan RK; Merriman R; Feng S; Freise CE; Ascher NL; Roberts JP Liver Transpl; 2005 Dec; 11(12):1505-14. PubMed ID: 16315294 [TBL] [Abstract][Full Text] [Related]
13. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria. Herrero JI; Sangro B; Pardo F; Quiroga J; Iñarrairaegui M; Rotellar F; Montiel C; Alegre F; Prieto J Liver Transpl; 2008 Mar; 14(3):272-8. PubMed ID: 18306328 [TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome. Arikan C; Kilic M; Nart D; Ozgenc F; Ozkan T; Tokat Y; Yagci RV; Aydogdu S Pediatr Transplant; 2006 Feb; 10(1):42-7. PubMed ID: 16499586 [TBL] [Abstract][Full Text] [Related]
15. The best candidates for transarterial chemotherapy in patients with hepatocellular carcinoma awaiting liver transplantation: a cohort-based characterization of dropout times. Jang JW; Choi JY; Bae SH; Kim CW; Cho SH; Yoon SK; Yang JM; Han JY; Lee YS; Kim DG Aliment Pharmacol Ther; 2007 Jul; 26(1):87-94. PubMed ID: 17555425 [TBL] [Abstract][Full Text] [Related]
16. Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma. Baccarani U; Benzoni E; Adani GL; Avellini C; Lorenzin D; Sainz-Barriga M; Bresadola V; Uzzau A; Risaliti A; Beltrami CA; Bresadola F Transplant Proc; 2007; 39(6):1898-900. PubMed ID: 17692647 [TBL] [Abstract][Full Text] [Related]
17. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Shetty K; Timmins K; Brensinger C; Furth EE; Rattan S; Sun W; Rosen M; Soulen M; Shaked A; Reddy KR; Olthoff KM Liver Transpl; 2004 Jul; 10(7):911-8. PubMed ID: 15237377 [TBL] [Abstract][Full Text] [Related]
18. An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution. Shah SA; Cleary SP; Tan JC; Wei AC; Gallinger S; Grant DR; Greig PD Ann Surg Oncol; 2007 Sep; 14(9):2608-14. PubMed ID: 17522942 [TBL] [Abstract][Full Text] [Related]
19. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. Piscaglia F; Camaggi V; Ravaioli M; Grazi GL; Zanello M; Leoni S; Ballardini G; Cavrini G; Pinna AD; Bolondi L Liver Transpl; 2007 Jun; 13(6):857-66. PubMed ID: 17539006 [TBL] [Abstract][Full Text] [Related]
20. Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study. Figueras J; Ibañez L; Ramos E; Jaurrieta E; Ortiz-de-Urbina J; Pardo F; Mir J; Loinaz C; Herrera L; López-Cillero P; Santoyo J Liver Transpl; 2001 Oct; 7(10):877-83. PubMed ID: 11679986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]